Advertisement
Canada markets close in 1 hour 24 minutes
  • S&P/TSX

    22,269.33
    +9.86 (+0.04%)
     
  • S&P 500

    5,179.04
    -1.70 (-0.03%)
     
  • DOW

    38,846.78
    -5.49 (-0.01%)
     
  • CAD/USD

    0.7278
    -0.0043 (-0.58%)
     
  • CRUDE OIL

    78.52
    +0.04 (+0.05%)
     
  • Bitcoin CAD

    86,667.71
    +122.29 (+0.14%)
     
  • CMC Crypto 200

    1,310.10
    -55.02 (-4.03%)
     
  • GOLD FUTURES

    2,323.50
    -7.70 (-0.33%)
     
  • RUSSELL 2000

    2,070.38
    +9.71 (+0.47%)
     
  • 10-Yr Bond

    4.4490
    -0.0400 (-0.89%)
     
  • NASDAQ

    16,304.73
    -44.52 (-0.27%)
     
  • VOLATILITY

    13.32
    -0.17 (-1.26%)
     
  • FTSE

    8,313.67
    +100.18 (+1.22%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • CAD/EUR

    0.6768
    -0.0024 (-0.35%)
     

Stocks in play: BELLUS Health Inc.

Announced that Dr. Denis Garceau, BELLUS Health's Senior Vice President, Drug Development, will present the Company's lead drug candidate for the treatment of chronic cough, BLU-5937, at the 2018 International Cough Symposium in London, England on Wednesday June 27. BELLUS Health Inc. shares T.BLU are trading unchanged at $0.53.